The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic

The Center for Cancer &Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating 1st community oncology patient